National Institute of General Medical Sciences; Notice of Closed Meeting, 39082-39083 [E9-18490]
Download as PDF
39082
Federal Register / Vol. 74, No. 149 / Wednesday, August 5, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Meeting
srobinson on DSKHWCL6B1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Child Health and
Human Development Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The intramural programs
and projects and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the intramural programs and projects,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Child Health and Human Development
Council NACHHD Subcommittee on
Planning and Policy.
Date: August 24, 2009.
Open: 10 a.m. to 11 a.m.
Agenda: Topics to be discussed include:
(1) Report of the Director; (2) Budget
Updates; (3) Legislative Updates.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Room 2A03,
Bethesda, MD 20892. (Telephone Conference
Call).
Closed: 11 a.m. to 12 p.m.
Agenda: To review and evaluate the
Division of Intramural Research site visit
report.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Room 2A03
Bethesda, MD 20892. (Telephone Conference
Call).
Contact Person: Elizabeth Wehr, Senior
Public Health Analyst, Office of Science
Policy, Analysis and Communication,
NICHD/NIH/DHHS, 31 Center Drive, Suite
2A–18, Bethesda, MD 20892, 301–496–0805.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the Executive
Secretary’s need for confirmation from
subcommittee members on their availability
to participate in this meeting. Information is
also available on the Institute’s/Center’s
home page: https://www.nichd.nih.gov/about/
VerDate Nov<24>2008
18:54 Aug 04, 2009
Jkt 217001
nachhd.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: July 28, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–18487 Filed 8–4–09; 8:45 am]
BILLING CODE 4140–01–M
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.701, ARRA
Related Biomedical Research and Research
Support Awards., National Institutes of
Health, HHS)
Dated: July 28, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–18488 Filed 8–4–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of General Medical
Sciences; Notice of Closed Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences, Special Emphasis
Panel ARRA Grant Opportunities—Image
Resource for Biology—ZGM1 CBB–4 (IR)
Date: August 14, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Mona R. Trempe, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12, Bethesda, MD
20892, 301–594–3998,
trempemo@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
General Medical Sciences, Special Emphasis
Panel, ARRA Grant Opportunities—
Multifunctional Particles for Targeting and
Delivery—ZGM1 CBB–4 (MP).
Date: August 12, 2009.
Time: 10:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Mona R. Trempe, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12, Bethesda, MD
20892. 301–594–3998.
trempemo@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.701, ARRA
Related Biomedical Research and Research
E:\FR\FM\05AUN1.SGM
05AUN1
Federal Register / Vol. 74, No. 149 / Wednesday, August 5, 2009 / Notices
Support Awards, National Institutes of
Health, HHS)
ACTION: Notice of privacy act system of
records.
Dated: July 28, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–18490 Filed 8–4–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Request for Information
Notice is hereby given of a Request for
Information (RFI): Updating the
Interagency Autism Coordinating
Committee Strategic Plan for Autism
Spectrum Disorder (ASD) Research,
NOT-MH-09-013, issued by the National
Institute of Mental Health on behalf of
the Interagency Autism Coordinating
Committee (IACC).
The purpose of this RFI is to request
input from ASD stakeholders to inform
the next update of the Strategic Plan.
Please see the official RFI notice at
https://grants.nih.gov/grants/guide/
notice-files/NOT-MH-09-013.html for
more information and instructions for
responding by the deadline of August
21, 2009. All responses must be
submitted electronically via the Webbased form found at https://
www.acclaroresearch.com/oarc/rfi/.
Contact Person: Attention: RFI on
Updating the Strategic Plan for ASD
Research, Office of the Director,
National Institute of Mental Health,
NIH, 6001 Executive Boulevard, Room
8235, MSC 9669, Bethesda, MD 20892–
9669, iacc@mail.nih.gov.
Information about the IACC is
available on the Web site: https://
www.iacc.hhs.gov.
Dated: July 29, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–18704 Filed 8–4–09; 8:45 am]
BILLING CODE 4140–01–P
srobinson on DSKHWCL6B1PROD with NOTICES
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
[Docket No. DHS–2009–0050]
Privacy Act of 1974: U.S. Immigration
and Customs Enforcement—005 Trade
Transparency Analysis and Research
(TTAR) System of Records
AGENCY:
Privacy office, DHS.
VerDate Nov<24>2008
18:54 Aug 04, 2009
Jkt 217001
SUMMARY: U.S. Immigration and
Customs Enforcement (ICE) is republishing the system of records notice
(SORN) for the Trade Transparency
Analysis and Research (TTAR) system.
No comments were received through the
Federal Register comment procedure.
TTAR contains trade and financial data
that is analyzed to generate leads for
and otherwise support ICE
investigations of trade-based money
laundering, contraband smuggling, trade
fraud, and other financial crimes. The
data in TTAR is generally maintained in
the ICE Data Analysis and Research
Trade Transparency System (DARTTS),
a software application and data
repository that conducts analysis of
trade and financial data to identify
statistically anomalous transactions that
may warrant investigation for money
laundering or other import-export
crimes. Additionally, a Privacy Impact
Assessment for DARTTS has been
posted on the Department’s privacy Web
site. (See www.dhs.gov/privacy and
follow the link to ‘‘Privacy Impact
Assessments.’’) A final rule is also being
published in this issue of the Federal
Register in which the Department
exempts portions of this system of
records from one or more provisions of
the Privacy Act because of criminal,
civil, and administrative enforcement
requirements.
DATES: The established system of
records was effective as of December 1,
2008, based upon the prior TTAR
system of records notice published on
October 31, 2008.
ADDRESSES: You may submit comments,
identified by docket number DHS–
2009–0050 by one of the following
methods:
• Federal e-Rulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Fax: 703–483–2999.
• Mail: Mary Ellen Callahan, Chief
Privacy Officer, Privacy Office,
Department of Homeland Security,
Washington, DC 20528.
• Instructions: All submissions
received must include the agency name
and docket number for this rulemaking.
All comments received will be posted
without change to https://
www.regulations.gov, including any
personal information provided.
• Docket: For access to the docket, to
read background documents, or
comments received go to https://
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Lyn
Rahilly, Privacy Officer, (202–732–
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
39083
3300), U.S. Immigration and Customs
Enforcement, 500 12th Street, SW.,
Washington, DC 20024, e-mail:
ICEPrivacy@dhs.gov, or Mary Ellen
Callahan (703–235–0780), Chief Privacy
Officer, Privacy Office, U.S. Department
of Homeland Security, Washington, DC
20528.
SUPPLEMENTARY INFORMATION:
I. Background
The Trade Transparency Analysis and
Research (TTAR) system of records is
owned by the ICE Office of
Investigations Trade Transparency Unit
(TTU) and is maintained for the purpose
of enforcing criminal laws pertaining to
trade through trade transparency. Trade
transparency is the concept of
examining U.S. and foreign trade data to
identify anomalies in patterns of trade.
Such anomalies can indicate tradebased money laundering or other
import-export crimes that ICE is
responsible for investigating, such as
contraband smuggling, trafficking of
counterfeit goods, misclassification of
goods, and the over- or under-valuation
of goods to hide the proceeds of illegal
activities. TTAR contains trade and
financial data received from U.S.
Customs and Border Protection (CBP),
U.S. Department of the Treasury
Financial Crimes Enforcement Network
(FinCEN), other Federal agencies and
foreign governments. TTAR data is
primarily related to international
commercial trade and contains little
information on the normal day-to-day
activities of individual consumers.
As part of the trade transparency
investigative process, ICE investigators
and analysts must understand the
relationships between importers and
exporters and the financing for a set of
trade transactions to determine which
transactions are suspicious and warrant
investigation. If performed manually,
this process often involves hours of
analysis of voluminous data for a
particular case or operation. To
automate and expedite this process, the
former U.S. Customs Service created the
Data Analysis and Research Trade
Transparency System (DARTTS), a
software application and data repository
that conducts analysis of trade and
financial data to identify statistically
anomalous transactions that may
warrant investigation for money
laundering or other import-export
crimes. DARTTS is specifically
designed to make this investigative
process more efficient by automating the
analysis and identification of anomalies
for the investigator. While DARTTS
does increase the efficiency of data
analysis, DARTTS does not allow ICE
E:\FR\FM\05AUN1.SGM
05AUN1
Agencies
[Federal Register Volume 74, Number 149 (Wednesday, August 5, 2009)]
[Notices]
[Pages 39082-39083]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-18490]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences, Special Emphasis Panel, ARRA Grant Opportunities--
Multifunctional Particles for Targeting and Delivery--ZGM1 CBB-4
(MP).
Date: August 12, 2009.
Time: 10:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Mona R. Trempe, PhD, Scientific Review Officer,
Office of Scientific Review, National Institute of General Medical
Sciences, National Institutes of Health, 45 Center Drive, Room
3AN12, Bethesda, MD 20892. 301-594-3998. trempemo@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.701, ARRA Related Biomedical
Research and Research
[[Page 39083]]
Support Awards, National Institutes of Health, HHS)
Dated: July 28, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-18490 Filed 8-4-09; 8:45 am]
BILLING CODE 4140-01-M